Related Experiment Video

Updated: Oct 9, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma

M J Droller

    The Journal of Urology
    |March 10, 2001
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
    09:28

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

    Published on: May 12, 2019

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
    07:34

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

    Published on: November 17, 2023

    Related Experiment Videos

    Last Updated: Oct 9, 2026

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
    09:28

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

    Published on: May 12, 2019

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
    07:34

    Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

    Published on: November 17, 2023

    Related Concept Videos

    Cancer Stem Cells and Tumor Maintenance02:40

    Cancer Stem Cells and Tumor Maintenance

    Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
    Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

    Articles linked to this work by shared authors, journal, and citation graph.

    Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors.

    Urologic oncology·2011

    Risk factors in clonal development from superficial to invasive bladder cancer.

    Cancer surveys·2004

    Putative protein markers in the sera of men with prostatic neoplasms.

    BJU international·2003

    Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer.

    Prostate cancer and prostatic diseases·2002

    Urology in the twenty-first century: noninvasive targeted treatments for urologic malignancies.

    World journal of surgery·2000

    Current concepts in assessment and treatment of bladder cancer.

    Current opinion in urology·2000

    Anatomical Mapping of Lymphatic Leakage Leading to Symptomatic Lymphoceles Formation After Pelvic Lymph Node Dissection for Prostate Cancer.

    The Journal of urology·2026

    Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography / Magnetic Resonance Imaging in Selected Men with Equivocal Prostate Imaging Reporting and Data System Category 3 Lesion (PANDORA): A Prospective Paired Diagnostic Study.

    The Journal of urology·2026

    Post-chemotherapy retroperitoneal lymph node dissection following first-line treatment in patients with advanced pure seminoma of the testis.

    The Journal of urology·2026

    Urgency Urinary Incontinence Is Associated with Vascular Comorbidity and Erectile Dysfunction: A LURN Cohort Analysis.

    The Journal of urology·2026

    Inherited Predisposition in Steroidogenic Pathways and Risk of Transition to Incurable Prostate Cancer in men with Localized Disease.

    The Journal of urology·2026

    A Phase I Clinical Trial of Chemoimmunotherapy With Alternating Intravesical Gemcitabine and Bacillus Calmette-Guérin (GemBCG) for BCG-Exposed High-Grade Non-Muscle-Invasive Bladder Cancer.

    The Journal of urology·2026

    Dual use of e-cigarettes and combustible cigarettes elevates salivary DKK1 levels similar to exclusive smoking.

    Frontiers in public health·2026

    scTIME: single-cell-informed interpretable modeling of immunotherapy-associated immune states in non-small cell lung cancer.

    Frontiers in artificial intelligence·2026

    High-volume cervical lymph node metastasis in papillary thyroid carcinoma: development and external validation of an interpretable prediction model.

    Frontiers in oncology·2026

    Development of the LARyNGTH score to predict central neurogenic respiratory failure in lateral medullary infarction.

    Frontiers in neurology·2026

    Predictive value of multimodal models combining CT body composition and clinical variables for short-term postoperative complications in colorectal cancer: a systematic review and meta-analysis.

    Frontiers in nutrition·2026

    Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After Intervention.

    International journal of MS care·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us